Electronic Code of Federal Regulations
|
e-CFR data is current as of July 10, 2020 |
Title 21 → Chapter I → Subchapter E → Part 522 → §522.1920 |
Title 21: Food and Drugs
PART 522—IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS
§522.1920 Prochlorperazine and isopropamide.
(a) Specifications. Each milliliter of solution contains prochlorperazine edisylate equivalent to 4 milligrams (mg) prochlorperazine and isopropamide iodide equivalent to 0.28 mg of isopropamide.
(b) Sponsor. See No. 054771 in §510.600(c) of this chapter.
(c) Conditions of use—(1) Amount. (i) Dosage is administered by subcutaneous injection twice daily as follows:
| Weight of animal in pounds | Dosage in milliliters |
|---|---|
| Up to 4 | 0.25 |
| 5 to 14 | 0.5-1 |
| 15 to 30 | 2-3 |
| 30 to 45 | 3-4 |
| 45 to 60 | 4-5 |
| Over 60 | 6 |
(ii) Following the last injection, administer prochlorperazine and isopropamide sustained release capsules as indicated.
(2) Indications for use. For use in dogs and cats in which gastrointestinal disturbances are associated with emotional stress.
(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[79 FR 16194, Mar. 25, 2014]